External
Affairs
Women's
Health and Federal Policy
By Joanne
L. Hustead, JD; Donald
W. Parsons, MD
Historical
Background
Until the latter part of the 20th century, the only women's health issues
recognized by policymakers were those related to women's childbearing
capacity. As a result, early debates over women's health were characterized
by misguided and artificially narrow views of the policies and changes
necessary to meet women's real health care needs.
From
the early days of Margaret Sanger and fights over the legality of contraception
to the high-pitched battle over the right to legal abortionand to today's
struggles to cure diseases like breast cancer and to raise awareness
about women and heart diseasewomen have organized around health issues
and have struggled to gain recognition of their unique health needs
as well as the broad range of women's health concerns.
Expanding
Recognition of Women's Health Needs
Women's greater use of health care services and their tendency to orchestrate
health care for other members of the family (young and old) make nearly
every pressing health care issue of the day a women's health issue as
well. These issues include the need for universal health insurance coverage,
the need for strong patient protections, and the need for a Medicare
prescription drug benefit. As they take on these and other 21st-century
battles, women and women's organizations are building on the groundbreaking
efforts of the women who came before them.
The
last decade of the 20th century was a time of great policy changes.
Women brought their exclusion from clinical trials to the Congress and
to the public and demandedand woninclusion. Advocates for women with
breast cancer, ovarian cancer, osteoporosis, and other diseases that
predominantly or exclusively affect women organized and started to change
public attitudes and public policy. The Family and Medical Leave Act,1
signed into law in 1993, recognized the expanding role of women in the
workplace and the needs of women and men to balance their dual
roles as breadwinners and caregivers. The Violence Against Women Act
(VAWA)2 was passed in 1994 and energized the public discussion
around domestic violence as an important health issue.
Gender-Specific
Medicine
As we enter a new era of booming medical technology, many challenges
remain. One of the most important challenges, stemming from the historical
exclusion of women from clinical research, is the need to better understand
the biological differences between men and women and how various diseases
and their treatments affect women. This clinically important area is
known as "gender-specific" medicine. The right to inclusion
in clinical research isn't enough; researchers need to analyze scientific
and clinical data by gender if we are to gain greater insight into biological
differences between the sexes.
Human
Genome Research
Advances in the understanding of the human genome raise especially pressing
concerns. Women have been at the forefront of the genetic revolution
for many yearsfirst because of their involvement with prenatal testing,
and then with the discovery of the BRCA1 and BRCA2 genes a few years
ago. These discoveries made it possible to identify some women at higher
risk for breast or ovarian cancer. Greater understanding of the cause
of disease brings the hope for insight into treatment and prevention,
but it opens a Pandora's box of potential discrimination if information
passes into the wrong handsemployers or insurers, for example. Some
women have indicated a reluctance to be tested: they fear that the act
of testing will itself alarm a wary employer and may lead to loss of
a promotion, loss of insurability, or even loss of a job.
Recent
advances by the Human Genome Project promise increased ability to predict
other genetic diseases (and perhaps, ultimately, most chronic diseases)
in the future. The Coalition for Genetic Fairness,3 spearheaded
by the National Partnership for Women & Families and comprising
dozens of advocacy organizations concerned with known or suspected genetic
diseases, is actively seeking stronger federal protection against misuse
of genetic information as part of a Patients' Bill of Rights or through
separate legislation. Such protection would build on the Health Insurance
Portability and Accountability Act of 1996 (HIPAA),4 which
provides that employment-based group health plans cannot discriminate
against present or potential policyholders on the basis of genetic information.
HIPAA also provides that genetic information alone cannot be treated
as a "pre-existing condition."
Privacy
of Medical Information
Meanwhile, Congress continues its struggle with the question of how
to guarantee the privacy of all medical information, including genetic
information. Proposed regulations promulgated by the Secretary of Health
and Human Services at the close of 19995 respond to many
privacy concerns, but specific Congressional action may be needed before
all parties feel a sense of trust. Most observers believe that Congressional
action on comprehensive medical privacy legislation is not likely to
happen this year. However, the computer revolution and an everchanging
health care system that places private medical information into many
hands will keep the issue in the public eye.
The
Breast and Cervical Cancer Treatment Act
More likely to gain Congressional approval this year is an important
program to provide treatment for low-income, uninsured women diagnosed
with breast or cervical cancer. The Centers for Disease Control and
Prevention (CDC) established a national breast and cervical cancer screening
program for low-income, uninsured women in 1990,6 but this
program did not guarantee treatment for women who had positive screening
test results. The Breast and Cervical Cancer Treatment Act7 has
been introduced to fill this gap by providing for Medicaid coverage
through a new state option. This proposal was passed in early May by
the US House of Representatives with one dissenting vote and is likely
to be enacted into law this year.
The
Family and Medical Leave Act
Women are the nation's primary health care consumers and caregivers.
Nonetheless, many women still have an unmet need for time off from work
to care for themselves or a family member or to have a child. The Family
and Medical Leave Act (FMLA),1 which provides job protection
and continuous health insurance for people who need time off from work
because of childbirth or adoption, family illness, or their own serious
medical condition, has been embraced and applauded by employers and
politicians alike. However, only businesses that employ 50 or more people
are required to comply with this law. Efforts are underway to expand
the scope of the FMLA to include midsized businesses (ie, those with
25 to 49 employees), expand opportunities for taking leave from work,
and expand sources of funding such leavefor example, unemployment insurance
and disability insurance. The federal government has issued a final
regulation8 to clarify that states can use unemployment funds
for this purpose. States are also addressing this issue. This year Minnesota
considered financial incentives for employers, and California,
Illinois, New York, Connecticut, and New Hampshire
already have authorized studies of ways to make family leave more
affordable.9
Women's
Safety Legislation
Other bills pending or proposals under consideration include a reauthorization
of VAWA, and VAWA II,10 which, among other things, would
build on HIPAA by prohibiting health insurance discrimination against
victims of domestic violence in more markets.4 In addition,
California Congressman Fortney (Pete) Stark has introduced legislation
to establish federal standards for use of safer needles to protect the
nursing and health care technician workforce (predominantly female)
against needle-stick injuries.11
When
Will Women's Health Policy Meet Women's Needs?
Many women's organizations are still working hard to bring this diverse
range of issues to the attention of the public and policymakers, but
much work remains to be done before women's health policy evolves to
meet women's needs. With all this attention, women's health, social,
environmental, and workplace concerns can no longer be ignored.
References
1. Family and Medical Leave Act of 1993, Pub L No. 103-3, 107 Stat 6.
(Feb. 5, 1993).
2. Violence Against Women Act (VAWA) of 1994, Pub L No. 103-322, 108
Stat 1796. (Sept 13, 1994).
3. Coalition for Genetic Fairness. http://www.nationalpartnership.org/healthcare/genetic/coalition.htm.
4. Health Insurance Portability and Accountability Act of 1996 (HIPAA),
Pub L No. 104-191, 110 Stat 1936 (Aug 21, 1996). [For more information
on HIPAA, visit the National Partnership's Web page (http://www.nationalpartnership.org/healthcare/hipaa/guide.htm)
and read or download the HIPAA guide. HIPAA also provides some protection
for victims of domestic violence from discrimination by employment-based
group health plans.]
5. Department of Health and Human Services. Secretary of Health and
Human Services. Proposed rule: medical privacy. 64 Fed Reg 59918 (Nov
3, 1999).
6. Centers for Disease Control and Prevention. National Center for Chronic
Disease Prevention and Health Promotion. Cancer Prevention and Control
National Breast and Cervical Cancer Early Detection Program. http://www.cdc.gov/cancer/nbccedp/index.html.
7. Breast and Cervical Cancer Treatment Act of 1999, [pending], S 662,
106th Cong, 1st Sess (1999); Breast and Cervical Cancer Prevention and
Treatment Act of 2000, HR 4386, 106th Cong, 2nd Sess (2000).
8. 65 Fed Reg 37210 (June 13, 2000).
9. For more information on the FMLA and state proposals to make family
and medical leave more affordable, visit the National Partnership's
Web page (http://www.nationalpartnership.org/workandfamily/workmain.htm).
10. Violence Against Women Act II (VAWA II), [pending] S 51, 106th Cong,
1st Sess. (1999).
11. Health Care Worker Needlestick Prevention Act, [pending] HR 1899,
106th Cong, 1st Sess (1999).